Biogen Inc.’s new at-home Alzheimer’s drug will give the company an edge over rival Eli Lilly Co.’s competing therapy, its ...
BGI Genomics and Roche Diagnostics have rolled out tests for Alzheimer's disease in China, the companies said, in an effort ...
A 2022 study out of Griffith University in Australia found that nose picking can usher Chlamydia pneumoniae, bacteria that ...
The Brighterside of News on MSN
Experimental drug can sharply reduce amyloid beta's impact on Alzheimer’s
Early in Alzheimer’s disease, your brain can begin to change long before anyone notices a lost name or missed appointment.
Researchers have added to a stack of existing evidence that 40 Hz gamma frequencies could help to treat Alzheimer's disease.
Three years after the accelerated approval of its anti-amyloid Alzheimer’s therapy, Biogen—neck and neck in the market with ...
KSNW Wichita on MSN
Endowment set up for Alzheimer’s and dementia research at Wichita’s KU Med
WICHITA, Kan. (KSNW) — A $25,000 endowed fund has been established for the University of Kansas School of Medicine-Wichita to ...
Swiss drugmaker Novartis has signed a licensing deal worth nearly $1.7 billion with privately held SciNeuro Pharmaceuticals ...
You think you’re fine. Your family and friends think you’re fine. But, just maybe, you’re not. Maybe you already have Alzheimer’s disease, but you just don’t know it yet, because it can begin ...
While a blood test to look for Alzheimer’s is a monumental leap, and is a great source of hope, we need to remember that a ...
Johns Hopkins researchers identified a new target for treating Alzheimer’s disease by focusing on a protein that produces tiny amounts of hydrogen sulfide in healthy brain cells.
Giving away money is common in individuals with Alzheimer's or dementia. Whether it is writing checks to various charities or ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results